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a b s t r a c t
Objective: There is no existing standard, evidence-based, scientiﬁc model for motor ability
improvement in Huntington's Disease (HD) patients aimed at maintaining independent gait
for as long as possible, or performing activities of daily living, the effectiveness of which
would be supported by the results of studies using objective research tools. Under these
circumstances, the aim of this study was to analyze the inﬂuence of motor ability rehabili-
tation on the spatial-temporal parameters of gait in HD patients.
Design: Itwasanexperimental trial. Thestudiedgroupconsistedof 30patients (17womenand13
men) with HD. In hospital conditions, the patients participated in the 3-week motor ability l
rehabilitationprogrammetailoredtoindividualneeds.ThestudygroupwastestedusingtheVicon
250 three-dimensional gait analysis system before and after the physical exercise programme.
Results: Walking speed after therapy increased for the left lower limb from 1.06 (SD 0.24) [m/
s] to 1.21 (SD 0.23) [m/s], and for the right lower limb from 1.07 (SD 0.25) [m/s] to 1.20 (SD 0.25)
[m/s]. The cycle length increased after the applied therapy for the left lower limb from 1.17
(SD 0.20) [m] to 1.23 (SD 0.19) [m].
-week motor ability rehabilitation programme positively inﬂuences
parameters in HD patients.© 2018 Polish NeuConclusion: The three
spatial-temporal gaitrological Society. Published by Elsevier Sp. z o.o. All rights reserved.* Corresponding author.
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sive, incurable, hereditary disorder. Impairment of the
ability to walk independently may occur in many diseases.
Very often, abnormalities in gait pattern are due to diseases
of the nervous system. It is believed that gait analysis is the
best and only test for assessing pathologies of the nervous
system [1]. The abnormalities of gait occurring in HD were
qualiﬁed by Nutt as middle level gait disturbances, as a
result of a pathological condition, in particular within the
basal ganglia, caudate nucleus and cerebral cortex [2]. It can
therefore be assumed that a person with HD should have
his/her own characteristic pattern of gait disturbances, and
thanks to this knowledge, it would be possible to pro-
gramme an efﬁcient motor ability improvement process. In
addition, based on the available results of biomechanical
studies, we can conclude that kinematic and spatial-
temporal parameters of HD patients compared with healthy
individuals at the same age will be different [3,4]. The gait of
a HD patient is usually on a widened base. In the later stages
of HD, patients' gait becomes stiff, cautious and reduces in
speed. In addition, with the use of three-dimensional gait
analysis, the researchers found the following irregularities
during the gait cycle (stride): shortening the length of the
gait cycle, extending the duration of the double-support
phase, as well as an increase in the diversity of the duration
of the gait cycle and step compared to the control group [5–
7]. Gait instability, along with imbalances as well as
psychiatric and cognition disturbances signiﬁcantly con-
tribute to falls, which occur in approximately 60% of
patients with HD. The risk of falls increases with the
progression of this disease [8].
An important aspect of the therapeutic process in HD, in
addition to pharmacological treatment, is physiotherapy,
which allows to counteract the effects of disease progres-
sion and preserve independent functioning of patients for
as long as possible. This theory is conﬁrmed by the
biological basis of neurorehabilitation and the results of
research on the effectiveness of physiotherapy in other
diseases such as e.g. Parkinson's disease or strokes [9–11].
In 2009, The European Huntington's Disease Network's
Working Group of Physiotherapy published a guide on
physiotherapy in HD, including, among others, standard-
ized assessment of the physical condition of the patients
and aims of physiotherapy. In the process of gait re-
education, a physiotherapist can use the following strate-
gies: stimulation of physical activity by teaching in the form
of tasks, learning how to fall and stand up from the ground,
training balancing strategies, strengthening the postural
muscles [12]. There is no existing standard, evidence-based,
scientiﬁc model for motor ability improvement aimed at
maintaining independent gait for as long as possible, or
performing activities of daily living, the effectiveness of
which would be supported by the results of studies using
objective research tools. Under these circumstances, the
aim of this study was to analyze the inﬂuence of motor
ability rehabilitation on the spatial-temporal parameters of
gait in HD patients.2. Materials and methodsThis was an experimental trial. Patients with HD attending the
Enroll HD data at the Department of Neurology, [3_TD$DIFF]University
Hospital, Jagiellonian University in Krakow were recruited.
After giving their written consent, the eligible patients were
clinically examined by an experienced neurologist. Inclusion
criteria for the study were: HD diagnosis conﬁrmed by genetic
testing, HD motor manifestation at baseline neurological
examination, stable and optima pharmacotherapy at least
onemonth before the test and the patient's written consent to
participate in the study. While the criteria for exclusion from
the study included: abnormal gait preventing the subject to
independentlywalk a distance of 20 m in a straight line, severe
cognitive impairment MMSE < 20 score (moderate and severe
dementia), behavioural and/or psychotic disturbances pre-
venting effective cooperation, orthopaedic disorders and the
consequences of experiencing traumatic lesions to the motor
organ permanently disrupting gait pattern and the presence of
other chronic or acute conditions having signiﬁcant impact on
health, e.g. cancer, myocardial infarction, chronic pulmonary
disease.
Permission to conduct researchwas issued by the Bioethics
Committee of the [4_TD$DIFF]Approval No.: KBET/59B/2010 and proce-
dures were performed in accordance with the Declaration of
Helsinki. Trial ID: [5_TD$DIFF]ACTRN12617000094370.
Each patient always worked with their assigned, qualiﬁed
physiotherapist, and the level of difﬁculty of the motor tasks
was adapted to the patient's abilities. In hospital conditions,
the patients participated in the 3-week motor ability rehabili-
tation programme, which consisted of ﬁfteen, 90-minute
individual sessions conducted daily, excluding Saturdays
and Sundays.
The motor ability rehabilitation programme, whose main
objective was gait re-education, was created on the basis of
existing scientiﬁc reports, aswell as the experience and results
obtained in the evaluation of gait of patients via the Vicon
system. Special attention was paid to the correct position of
the pelvis, spinal curvatures, shoulder protraction, and the
position of the head, knees and feet during the execution of
movement by the patient. Throughout the duration of therapy,
emphasis was out on proper breathing patterns, separating
consecutive movement exercises by breathing exercises (e.g.
blowing up a balloon, blowing soap bubbles, blowing into a
tissue located at different distances from the mouth). To carry
out the motor tasks, such rehabilitation equipment as hand-
rails, mirrors, gymnastic balls, sensorimotor pillows, poles,
coloured tape and weights were used. During the session,
closed kinematic chains were used 70% of the time, and
through the use of combining the variousmovement patterns,
we obtained global activity of the patient's body. During the
motor ability improvement, we focused on increasing the
number of repetitions of amotor task, resigning from diversity
of exercise. Each session consisted of three parts:1. Introductory part – warm-up (duration: 10 min)
The aim was to raise awareness of one's own body, and
to improve spatial orientation. This also included learning
correct breathing patterns along with lively coordination
Table 1 – Characteristics of the study group.
Variable Study group
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throwing.2. M
Gender [female/male] 17/13
Age [years] 43.4  13.8
Disease duration [years] 7.0  5.8
Number of CAG repetitions 46.6  6.0
Body height [m] 1.67  0.1
Body mass [kg] 62.5  17.6
Walking speed [m/s] 1.07  0.25
Cadence [Hz] 107.6  15.6
Step length [m] 0.59  0.11
UHDRS motor [points] 40.8  20.0
UHDRS cognitive [points] 123.9  43.3
TFC [points] 7.7  3.1
UHDRS – Uniﬁed Huntington's Disease rating scale.
TFC – total functional capacity.ain part (duration: 70 min)
The aimwas tomobilize functional reserves through the
use of agonist/antagonist techniques, which help to learn
proper gait patterns by improving coordination, endurance,
balancing reactions and postural stability. This is achieved
by performing certain exercises:
- exercises on amat (position changes – turnover, the use of
the following positions for motor tasks: on one's stomach
supported by the forearms, lying on one's side, lateral
position, backbend, sitting ﬂat on the ground, supported
kneel, one leg/both leg kneel, standing position, balancing
positions, training balancing strategies)
- exercises in a seated position
- gait training (weight shifting, standing on one leg, walking
forwards, backwards, sideways, defensive steps, visual-
spatial coordination, obstacle course, stairs)3. Final part (duration: 10 min)
The objective was relaxation and tranquilization
through calm breathing exercises.
Patients who met the criteria took part in the research
Project including the Vicon 250 three-dimensional gait analy-
sis system and physical exercise programme. Gait analysis
using the Vicon 250 system took place in the Biokinetic
Laboratory at the Department of the Biomechanics [1_TD$DIFF]. The study
group was tested just before ﬁrst and just after last session of
the physical exercise programme. There was no time gap
before the rehabilitation process and patients' clinical rating
by Vicon 250.
The Vicon 250 system allowed to record and analyze
motion patterns in three-dimensional space. Registration of
gait with the Vicon 250 system was performed using passive
markers attached to speciﬁc anthropometric points directly on
the skin, based on the Golem biomechanical model (Oxford
Metrics Ltd.). During gait analysis, 30 steps performed on a 20-
m walking path were registered using ﬁve cameras operating
at a frequency of 120 Hz. The following spatial-temporal
parameters for left and right leg were analyzed: stride time,
stride length, step time, step length, cadence (step frequency),
ﬁrst double support, second double support, single limb
support, heel rise (end of stance phase) and gait speed.
Normality of data (score) distribution was veriﬁed using
Pearson's chi-squared test. Due to the fact that distribution of
the results did not ‘‘deviate’’ from the normal distribution in
any of the cases, parametric tests were used. The signiﬁcance
of differences in the average valueswas tested using the t-test,
where statistics have Student's t distribution. The level of
signiﬁcancewas assumed at p < 0.05. Statistical analysis of the
test resultswas performedusing Statistica 6.0 Pl Statsoft (USA).
3. ResultsThe studied group consisted of 30 patients (17 (57%) women
and 13 (43%) men) with HD. The characteristics of the study
group are presented in Table 1.
Comparison of mean values of selected spatio-temporal
parameters in HD patients before and after physical therapyare presented inTable 2. One of the twoparameters forwhich a
statistically signiﬁcant increasewasnoted in the average value
regarded walking speed, which increased for the left lower
limb from 1.06 (SD 0.24) [m/s] to 1.21 (SD 0.23) [m/s], and for the
right lower limb from 1.07 (SD 0.25) [m/s] to 1.20 (SD 0.25) [m/s].
The second parameter is cycle length, the value of which
signiﬁcantly increased after conducting therapy; the left lower
limb from 1.17 (SD 0.20) [m] to 1.23 (SD 0.19) [m]. For the
remaining analyzed variables, we observed changes aimed in
the direction of the reference group values, but they were not
statistically signiﬁcant.
4. DiscussionA signiﬁcant result obtained in the conducted studies is the
documented impact of the createdmotor ability rehabilitation
programmeonthe increaseofwalkingspeed inpeoplewithHD.
The study group obtained a statistically signiﬁcant improve-
ment in thestride lengthonly for the left side. Itmayresult from
heterogeneity in terms of severity of symptoms within the
study group or asymmetry appearing in the gait pattern of HD
patients. In order to explain differences between left and right
stride length, theexaminationofa largergroupisnecessary.For
the other analyzed spatial-temporal parameters, changes
towards normative values were observed, although they were
not statistically signiﬁcant. The reason for this may be the
insufﬁcient duration of the motor ability rehabilitation pro-
gramme. In the light of the available literature, multidisciplin-
ary rehabilitation programmes for HD lasting 9, 18 and 24
months, respectively, resulted in signiﬁcant improvement
regardingmotor and cognitivedisorders [13,14]. Unfortunately,
the time limit of our research imposing a 3-week hospitaliza-
tion period was dictated by the guidelines of the National
Health Fund. The advantage of the patients staying at the
hospital was standardization of circadian rhythm. There was
no possibility for out-patient research, since the patients came
from the Malopolska, Podkarpackie and Silesia voivodeships.
The use of objective measuring devices, such as Vicon system,
allows to recordandanalyzegait changes in three-dimensional
space [12,15].
The literature on gait disturbances in HD, available in
PubMed, Scopus and Pedro is relatively sparse. In several of
Table 2 – Comparison of mean values for selected spatial-temporal parameters of HD patients before and after physical
therapy.
The analyzed spatial-temporal parameter Limb Before therapy After therapy t df Statistical signiﬁcance (p)
x SD x SD
Stride time [s] L 1.15 0.19 1.10 0.17 0.96 58 0.34
R 1.15 0.21 1.10 0.21 0.96 58 0.34
Stride length [m] L 1.17 0.20 1.23 0.19 2.54 58 0.01
R 1.18 0.21 1.26 0.18 1.56 58 0.13
Step time [s] L 0.58 0.09 0.59 0.15 0.39 58 0.70
R 0.57 0.10 0.57 0.14 0.05 58 0.96
Step length [m] L 0.59 0.10 0.64 0.10 1.83 58 0.07
R 0.59 0.11 0.63 0.10 1.51 58 0.14
Cadence [steps/min] L 107.63 15.58 111.76 15.06 1.03 58 0.31
R 107.79 16.56 111.68 15.80 0.92 58 0.36
First double support [s] L 0.104 0.05 0.087 0.04 1.43 58 0.16
R 0.108 0.05 0.101 0.08 0.38 58 0.71
Second double support [s] L 0.22 0.09 0.19 0.12 1.10 58 0.28
R 0.21 0.10 0.20 0.14 0.48 58 0.64
Single limb support [s] L 0.46 0.08 0.46 0.06 0.27 58 0.79
R 0.47 0.08 0.46 0.06 0.81 58 0.42
Heel rise [%] L 58.9 3.49 57.9 4.46 1.01 58 0.32
R 59.5 3.36 58.6 3.66 0.99 58 0.32
Gait speed [m/s] L 1.06 0.24 1.21 0.23 2.46 58 0.02
R 1.07 0.25 1.20 0.25 2.02 58 0.04
L – left, R – right, df – degrees of freedom.
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6 to 30 patients with symptomatic HD, representing a variety
of age groups, and was always compared with a reference
group comprised of 15–30 healthy age-matched participants
[5–7,16–18]. Most of the works concern the evaluation of
spatial-temporal parameters. So far, only 6 researchers
undertook the evaluation of patients using an electronic
system with passive markers used for three-dimensional
motion analysis. Among the three publications, we can ﬁnd
analysis of changes in kinematic parameters, and only one
publication analyses, according to the concept by Elftman,
the relations of the ‘‘locomotor’’ and ‘‘passenger’’ during gait
in people with HD [19].
The conducted review of existing literature relating to
treatment available in HD still shows an insufﬁcient number of
scientiﬁc reports conﬁrming the inﬂuence of physiotherapy on
kinematic and spatial-temporal parameters of gait in people
with HD [20]. The article by Busse et al. [21], based on surveys
conducted among physiotherapists who work with HD
patients every day, provides a good basis for the creation of
standards of conduct in the physiotherapy of people with HD,
and for the avoidance of basic mistakes in the course of
research planning. The research conducted by Khalil et al. [22],
Ulanowski [23] does not have clearly deﬁned criteria for
including/excluding patients from the study. These works
relate to the wider notion of physical activity. This, however,
gives reason to believe that properly conducted physiotherapy
by a qualiﬁed physiotherapist and at an appropriate frequency
may be included in the standards for treatment of HD patients.
It should also be noted that there are several articles on
comprehensive rehabilitation comprising of a plurality of
elements. However, the disadvantage of this type of research is
the very large number of factors affecting the physical and
mental health state of patients, thus it is difﬁcult to determinewhich aspect of therapy plays a key role. Much attention
should also be paid to the very low intensity of the conducted
interventions [24,25].
Following the review of literature, we only found one article
evaluating the effectiveness of motor rehabilitation in 12
people with HD using an objective electronic gait analysis
system in time and space related parameters (GAITRite
system) [26]. In addition, there were still three other articles
dealing with widely understood motor improvement in HD
patients using subjective methods for assessing effectiveness,
such as the Berg Balance Scale or the Up and Go test [21,22,24].
Bohlen et al. [26] are the only researchers so far who have
examined the effect of exercise on the gait of people with HD
using objective research tools. A 6-week motor ability
rehabilitation programme was carried out two times a week
for 1 hour in 12 HD patients without a control group. The
assessment was conducted using the GAITRite system and
additionally, clinical tests. The researchers demonstrated
statistically signiﬁcant differences in the length of the cycle
(increase), walking speed (increase) and the duration of the
double support phase (reduction) following treatment. Fur-
thermore, in clinical tests (BBS, TUG), signiﬁcant improvement
was not achieved after treatment [26]. Rehabilitation process
seems to improve gait function less than it was described in
previously published papers where not objective measure-
ments were used. Gait and balance analysis in patients with
the use of clinical tests is associated with a large margin of
error resulting from the different experience of clinicians and
the unreliability of human eyesight. In our study, signiﬁcant
improvement of spatial-temporal parameters after comple-
tion of the motor ability rehabilitation programme was
achieved only in increasing the walking speed and stride
length. The difference in results may be due to the signiﬁcant
divergence between the severity state of the movement
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the motor rehabilitation programme. Capato et al., conducted
a study assessing the impact of performing physical exercise
with carers of HD patients which lasted 60 days (once a week
for 45 min). Assessment before and after completion of the
exercises was performed using clinical tests (i.e. Berg Balance
Scale, Up and Go Test, 6-MinuteWalk Test). All 20 participants
with HD forming the test group achieved statistically signiﬁ-
cant improvement concerning every single of the conducted
tests [27].
The mechanisms of re-learning, improving movement
quality and the acquisition of new compensatory movement
patterns in diseases damaging the central nervous system are
probably supported by neuronal plasticity of the undamaged
brain areas. There is also scientiﬁc evidence that plasticity of
the damaged central nervous system can occur as a result of
the rehabilitation process. Researchers, analysing the nervous
system of patients undergoing rehabilitation after a stroke,
proved that thanks to movement therapy forced out of
necessity, the following occurs: reorganization of the move-
ment ﬁelds, an increase in the amplitude of evoked motor
potentials, as well as changes in brain activity observed using
functional magnetic resonance [28–31]. Moreover, in patients
with Parkinson's disease, it has been proven in studies using
functional magnetic resonance imaging that strength exer-
cises and pharmacology also cause changes in the patterns of
brain activity (the motor cortex), leading to alleviation of the
symptoms [32–34]. The results of the cited experiments allow
to presume that similar phenomena can occur during motor
ability rehabilitation of patients with Huntington's disease.
People with HD manifest problems in physical activity as
well as cognitive, emotional or social functions over an
extended period of time. One of the biggest difﬁculties in
creating comprehensive guidelines for physical therapy in
such neurodegenerative diseases as HD is the great heteroge-
neity of clinical symptoms. This problem is not unique toHD, it
relates to a general group of patients involved in neuroreh-
abilitation, such as individuals with Parkinson's disease, those
with lower lumbar pain or neck dysfunctions [35–37].
Some limitations of this study should, however, be
considered. Firstly, the number of tested persons is not
sufﬁcient – the amount does not make it possible to divide
the results depending on the severity of the disease, cognitive
disorders, behavioural disorders or type of drug therapy.
Secondly, the study group was very heterogeneous in terms of
severity of symptoms. Another limitation is lack of gait
assessment among the patients several weeks after the end
of the motor ability rehabilitation programme.
It is debatable whether using a protocol with a control
group without physiotherapy would provide any additional
information. In the conducted study, it was assumed that
maintaining stable drug therapy one month before the
beginning of the study and during its course (taking the
progressive nature of the disease into account), appropriately
minimizes distortion of the image of a patient's physical state,
resulting from the taken medication. The improvement of
motor disorders after application of antidopaminergic drugs in
HD patients is well known. In literature on the subject, there
are few publications regarding the effects of drug therapy on
gait in Huntington's disease. In their study, Koller et al.demonstrated that the use of haloperidol reduced the
occurrence of choreic movements, but does not affect walking
pattern [5]. The authors of other publications analysing
isolated cases of people with HD conclude that the use of
olanzapine and valproate can reduce the severity of move-
ment and psychotic disorders [38,39]. However, conducting
research among HD patients with clinical symptoms of the
disease but not yet pharmacologically treated should be
considered.
The three-week motor ability rehabilitation programme
showed improvement regarding the majority of abnormal
spatial-temporal gait parameters in patients with HD,
although, statistically signiﬁcant differences in gait before
and after motor rehabilitation were only obtained in increas-
ing walking speed for the lower left and right limbs, and an
increase in stride length for the left lower limb. It is probable
that the problems in planning and sequencing the motions
may lead to deceleration in speed of the performed locomotive
components, contributing to abnormal spatial-temporal gait
parameters [40,41].
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